Biosimilar Boom in China Heralded By First Approval

 
• By Brian Yang
  
Shanghai
Shanghai-Based Henlius Scores China's First Biosimilar Approval • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from China

More from Asia